CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer's Disease-A Narrative Review.
Neurol Ther
; 9(2): 419-434, 2020 Dec.
Article
in En
| MEDLINE
| ID: mdl-33089409
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
Language:
En
Journal:
Neurol Ther
Year:
2020
Document type:
Article
Affiliation country:
Bangladesh
Country of publication:
Nueva Zelanda